Johnson & Johnson Family of Companies
NEWS
The date set by the FDA’s independent advisors for debating that decision is Friday, February 26.
There’s plenty of COVID-19-related news today. Here’s a look.
It was a busy week for clinical trial announcements and news. Here’s a look.
South Africa recently announced it was halting distribution of the AstraZeneca-University of Oxford COVID-19 vaccine after data suggested it “provides minimal protection” against mild disease from the South African variant.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for February 9, 2021.
Johnson & Johnson’s Janssen Biotech submitted an application to the U.S. Food and Drug Administration (FDA) for emergency use authorization (EUA) for its single-dose COVID-19 vaccine.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for February 2, 2021.
Overall, against moderate-severe COVID-19 infection, the vaccine was 72% effective 28 days after vaccination in the U.S., 66% in hard-hit Latin America, and bottomed out at 57% in South Africa.
It was a busy week for clinical trial news. Read on for more information.
JOBS
IN THE PRESS